Detalhe da pesquisa
1.
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.
J Antimicrob Chemother
; 69(1): 12-20, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23934770
2.
Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatment.
Antimicrob Agents Chemother
; 57(1): 343-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23114756
3.
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
Antimicrob Agents Chemother
; 57(9): 4290-4299, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23796938
4.
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
J Antimicrob Chemother
; 68(2): 414-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23085775
5.
Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool.
J Clin Microbiol
; 50(6): 1936-42, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22403431
6.
The HIVdb system for HIV-1 genotypic resistance interpretation.
Intervirology
; 55(2): 98-101, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22286876
7.
Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes.
AIDS Res Ther
; 9(1): 13, 2012 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22554313
8.
The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance.
Bioinformatics
; 25(9): 1197-8, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19304876
9.
Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.
Antimicrob Agents Chemother
; 53(11): 4869-78, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19721070
10.
Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.
J Virol
; 82(21): 10747-55, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18715933
11.
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors.
Retrovirology
; 5: 74, 2008 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18687142
12.
HIV-1 subtype B protease and reverse transcriptase amino acid covariation.
PLoS Comput Biol
; 3(5): e87, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17500586
13.
Web resources for HIV type 1 genotypic-resistance test interpretation.
Clin Infect Dis
; 42(11): 1608-18, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16652319
14.
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.
PLoS One
; 9(8): e105569, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25140696
15.
Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.
PLoS One
; 8(6): e67188, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23840622
16.
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.
AIDS Res Hum Retroviruses
; 26(12): 1323-6, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20961278
17.
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.
Antiviral Res
; 88(3): 269-75, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20875460
18.
Predictive value of HIV-1 genotypic resistance test interpretation algorithms.
J Infect Dis
; 200(3): 453-63, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19552527
19.
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
PLoS One
; 4(3): e4724, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19266092
20.
Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance.
AIDS
; 22(6): 717-25, 2008 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-18356601